Chronic myeloid leukaemia (CML)
Chronic myeloid leukaemia (CML) is a type of blood cancer that affects a group of white blood cells known as myeloid cells.
Chronic myeloid leukaemia (CML) is a type of blood cancer that affects a group of white blood cells known as myeloid cells. Chronic means it is slow-growing.
Your body needs new blood cells all the time, which are all made in the bone marrow. In a healthy person, ‘starter cells’ in the bone marrow, called myeloid stem cells, develop into myeloid blasts, before eventually turning into mature (fully functioning) blood cells.
If you have CML, your body produces too many myeloid blasts and too many white blood cells called granulocytes. These cells overcrowd the bone marrow, meaning there isn’t enough room for other important blood cells to be made.
Some myeloid blasts also enter the bloodstream and, because they haven’t developed properly, stop your body from fighting infection properly.
There are three phases of CML: the chronic phase, the accelerated phase and the blast phase.
CML is more common in older people and very rare in children under 15. Around 750 people are diagnosed with CML each year in the UK.
Leukaemia (also spelled leukemia) is the name for a group of blood cancers that affect blood cells in your bone marrow – usually white blood cells. Leukaemia mostly affects adults but it can also happen in children.
There are different types of leukaemia. Some types are slow-growing (chronic) and some are fast-growing (acute).
We don’t know exactly what causes CML, but some things like age and sex make it more likely.
Half of people with CML are aged over 60 and it is slightly more common in men than women.
You’ll have tests to confirm whether you have CML. Then if you’re diagnosed with CML, you’ll have some more tests to help your healthcare team 'stage' the CML (find out which phase it's in), and decide which is the best treatment for you.
If you've just been diagnosed with CML
For support around a diagnosis of CML or any other blood cancer, go to our just diagnosed section.
The aim of treatment for CML is to reduce the number of myeloid blasts in your body to low enough levels for you to have a normal life expectancy.
Most people with CML take a daily dose of a drug called a tyrosine kinase inhibitor (TKI), which is taken orally (in tablet form).
If TKIs don't work for you, or if you're diagnosed with blast phase CML and treatment gets you back to the chronic phase, your doctor may recommend a stem cell transplant.
Thanks to treatment with TKIs, survival rates for CML have improved dramatically over the last 20 years.
For most people, the prognosis for CML will be very good – particularly for people diagnosed in the chronic phase.
Our pioneering research into chronic myeloid leukaemia (CML) has played a dramatic role in improving treatment and survival rates for CML.
If someone you know has blood cancer
If you're close to someone who's been diagnosed with blood cancer, you may find it helpful to read our information for family, friends and carers.